 | • レポートコード：MRC2-11QY10449 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はT細胞表面糖タンパク質CD4のグローバル市場について調査・分析したレポートです。種類別（酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他）市場規模、用途別（HIV、エイズ、GVHD、SARS、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別T細胞表面糖タンパク質CD4の競争状況、市場シェア ・世界のT細胞表面糖タンパク質CD4市場：種類別市場規模 2015年-2020年（酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他） ・世界のT細胞表面糖タンパク質CD4市場：種類別市場規模予測 2021年-2026年（酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他） ・世界のT細胞表面糖タンパク質CD4市場：用途別市場規模 2015年-2020年（HIV、エイズ、GVHD、SARS、その他） ・世界のT細胞表面糖タンパク質CD4市場：用途別市場規模予測 2021年-2026年（HIV、エイズ、GVHD、SARS、その他） ・北米のT細胞表面糖タンパク質CD4市場分析：米国、カナダ ・ヨーロッパのT細胞表面糖タンパク質CD4市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのT細胞表面糖タンパク質CD4市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のT細胞表面糖タンパク質CD4市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのT細胞表面糖タンパク質CD4市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biotest AG、Bristol-Myers Squibb Co、CEL-SCI Corp、Fountain Biopharma Inc、Immupharma Plc、Sanofi、TaiMed Biologics Inc、United Biomedical Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global T Cell Surface Glycoprotein CD4 Market
The global T Cell Surface Glycoprotein CD4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global T Cell Surface Glycoprotein CD4 Scope and Market Size
T Cell Surface Glycoprotein CD4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global T Cell Surface Glycoprotein CD4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the T Cell Surface Glycoprotein CD4 market is segmented into
Forigerimod Acetate
HIV Vaccine 2
Ibalizumab
Others
Segment by Application, the T Cell Surface Glycoprotein CD4 market is segmented into
HIV
AIDS
GVHD
SARS
Others
Regional and Country-level Analysis
The T Cell Surface Glycoprotein CD4 market is analysed and market size information is provided by regions (countries).
The key regions covered in the T Cell Surface Glycoprotein CD4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and T Cell Surface Glycoprotein CD4 Market Share Analysis
T Cell Surface Glycoprotein CD4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in T Cell Surface Glycoprotein CD4 business, the date to enter into the T Cell Surface Glycoprotein CD4 market, T Cell Surface Glycoprotein CD4 product introduction, recent developments, etc.
The major vendors covered:
Biotest AG
Bristol-Myers Squibb Co
CEL-SCI Corp
Fountain Biopharma Inc
Immupharma Plc
Sanofi
TaiMed Biologics Inc
United Biomedical Inc
1 Study Coverage
1.1 T Cell Surface Glycoprotein CD4 Product Introduction
1.2 Market Segments
1.3 Key T Cell Surface Glycoprotein CD4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Type
1.4.2 Forigerimod Acetate
1.4.3 HIV Vaccine 2
1.4.4 Ibalizumab
1.4.5 Others
1.5 Market by Application
1.5.1 Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Application
1.5.2 HIV
1.5.3 AIDS
1.5.4 GVHD
1.5.5 SARS
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global T Cell Surface Glycoprotein CD4 Market Size, Estimates and Forecasts
2.1.1 Global T Cell Surface Glycoprotein CD4 Revenue 2015-2026
2.1.2 Global T Cell Surface Glycoprotein CD4 Sales 2015-2026
2.2 Global T Cell Surface Glycoprotein CD4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global T Cell Surface Glycoprotein CD4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global T Cell Surface Glycoprotein CD4 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global T Cell Surface Glycoprotein CD4 Competitor Landscape by Players
3.1 T Cell Surface Glycoprotein CD4 Sales by Manufacturers
3.1.1 T Cell Surface Glycoprotein CD4 Sales by Manufacturers (2015-2020)
3.1.2 T Cell Surface Glycoprotein CD4 Sales Market Share by Manufacturers (2015-2020)
3.2 T Cell Surface Glycoprotein CD4 Revenue by Manufacturers
3.2.1 T Cell Surface Glycoprotein CD4 Revenue by Manufacturers (2015-2020)
3.2.2 T Cell Surface Glycoprotein CD4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global T Cell Surface Glycoprotein CD4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by T Cell Surface Glycoprotein CD4 Revenue in 2019
3.2.5 Global T Cell Surface Glycoprotein CD4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 T Cell Surface Glycoprotein CD4 Price by Manufacturers
3.4 T Cell Surface Glycoprotein CD4 Manufacturing Base Distribution, Product Types
3.4.1 T Cell Surface Glycoprotein CD4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T Cell Surface Glycoprotein CD4 Product Type
3.4.3 Date of International Manufacturers Enter into T Cell Surface Glycoprotein CD4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global T Cell Surface Glycoprotein CD4 Market Size by Type (2015-2020)
4.1.1 Global T Cell Surface Glycoprotein CD4 Sales by Type (2015-2020)
4.1.2 Global T Cell Surface Glycoprotein CD4 Revenue by Type (2015-2020)
4.1.3 T Cell Surface Glycoprotein CD4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global T Cell Surface Glycoprotein CD4 Market Size Forecast by Type (2021-2026)
4.2.1 Global T Cell Surface Glycoprotein CD4 Sales Forecast by Type (2021-2026)
4.2.2 Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Type (2021-2026)
4.2.3 T Cell Surface Glycoprotein CD4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global T Cell Surface Glycoprotein CD4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global T Cell Surface Glycoprotein CD4 Market Size by Application (2015-2020)
5.1.1 Global T Cell Surface Glycoprotein CD4 Sales by Application (2015-2020)
5.1.2 Global T Cell Surface Glycoprotein CD4 Revenue by Application (2015-2020)
5.1.3 T Cell Surface Glycoprotein CD4 Price by Application (2015-2020)
5.2 T Cell Surface Glycoprotein CD4 Market Size Forecast by Application (2021-2026)
5.2.1 Global T Cell Surface Glycoprotein CD4 Sales Forecast by Application (2021-2026)
5.2.2 Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Application (2021-2026)
5.2.3 Global T Cell Surface Glycoprotein CD4 Price Forecast by Application (2021-2026)
6 North America
6.1 North America T Cell Surface Glycoprotein CD4 by Country
6.1.1 North America T Cell Surface Glycoprotein CD4 Sales by Country
6.1.2 North America T Cell Surface Glycoprotein CD4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America T Cell Surface Glycoprotein CD4 Market Facts & Figures by Type
6.3 North America T Cell Surface Glycoprotein CD4 Market Facts & Figures by Application
7 Europe
7.1 Europe T Cell Surface Glycoprotein CD4 by Country
7.1.1 Europe T Cell Surface Glycoprotein CD4 Sales by Country
7.1.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe T Cell Surface Glycoprotein CD4 Market Facts & Figures by Type
7.3 Europe T Cell Surface Glycoprotein CD4 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific T Cell Surface Glycoprotein CD4 by Region
8.1.1 Asia Pacific T Cell Surface Glycoprotein CD4 Sales by Region
8.1.2 Asia Pacific T Cell Surface Glycoprotein CD4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific T Cell Surface Glycoprotein CD4 Market Facts & Figures by Type
8.3 Asia Pacific T Cell Surface Glycoprotein CD4 Market Facts & Figures by Application
9 Latin America
9.1 Latin America T Cell Surface Glycoprotein CD4 by Country
9.1.1 Latin America T Cell Surface Glycoprotein CD4 Sales by Country
9.1.2 Latin America T Cell Surface Glycoprotein CD4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America T Cell Surface Glycoprotein CD4 Market Facts & Figures by Type
9.3 Central & South America T Cell Surface Glycoprotein CD4 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa T Cell Surface Glycoprotein CD4 by Country
10.1.1 Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country
10.1.2 Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa T Cell Surface Glycoprotein CD4 Market Facts & Figures by Type
10.3 Middle East and Africa T Cell Surface Glycoprotein CD4 Market Facts & Figures by Application
11 Company Profiles
11.1 Biotest AG
11.1.1 Biotest AG Corporation Information
11.1.2 Biotest AG Description and Business Overview
11.1.3 Biotest AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biotest AG T Cell Surface Glycoprotein CD4 Products Offered
11.1.5 Biotest AG Related Developments
11.2 Bristol-Myers Squibb Co
11.2.1 Bristol-Myers Squibb Co Corporation Information
11.2.2 Bristol-Myers Squibb Co Description and Business Overview
11.2.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Products Offered
11.2.5 Bristol-Myers Squibb Co Related Developments
11.3 CEL-SCI Corp
11.3.1 CEL-SCI Corp Corporation Information
11.3.2 CEL-SCI Corp Description and Business Overview
11.3.3 CEL-SCI Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Products Offered
11.3.5 CEL-SCI Corp Related Developments
11.4 Fountain Biopharma Inc
11.4.1 Fountain Biopharma Inc Corporation Information
11.4.2 Fountain Biopharma Inc Description and Business Overview
11.4.3 Fountain Biopharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Products Offered
11.4.5 Fountain Biopharma Inc Related Developments
11.5 Immupharma Plc
11.5.1 Immupharma Plc Corporation Information
11.5.2 Immupharma Plc Description and Business Overview
11.5.3 Immupharma Plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Immupharma Plc T Cell Surface Glycoprotein CD4 Products Offered
11.5.5 Immupharma Plc Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi T Cell Surface Glycoprotein CD4 Products Offered
11.6.5 Sanofi Related Developments
11.7 TaiMed Biologics Inc
11.7.1 TaiMed Biologics Inc Corporation Information
11.7.2 TaiMed Biologics Inc Description and Business Overview
11.7.3 TaiMed Biologics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Products Offered
11.7.5 TaiMed Biologics Inc Related Developments
11.8 United Biomedical Inc
11.8.1 United Biomedical Inc Corporation Information
11.8.2 United Biomedical Inc Description and Business Overview
11.8.3 United Biomedical Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 United Biomedical Inc T Cell Surface Glycoprotein CD4 Products Offered
11.8.5 United Biomedical Inc Related Developments
11.1 Biotest AG
11.1.1 Biotest AG Corporation Information
11.1.2 Biotest AG Description and Business Overview
11.1.3 Biotest AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biotest AG T Cell Surface Glycoprotein CD4 Products Offered
11.1.5 Biotest AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 T Cell Surface Glycoprotein CD4 Market Estimates and Projections by Region
12.1.1 Global T Cell Surface Glycoprotein CD4 Sales Forecast by Regions 2021-2026
12.1.2 Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Regions 2021-2026
12.2 North America T Cell Surface Glycoprotein CD4 Market Size Forecast (2021-2026)
12.2.1 North America: T Cell Surface Glycoprotein CD4 Sales Forecast (2021-2026)
12.2.2 North America: T Cell Surface Glycoprotein CD4 Revenue Forecast (2021-2026)
12.2.3 North America: T Cell Surface Glycoprotein CD4 Market Size Forecast by Country (2021-2026)
12.3 Europe T Cell Surface Glycoprotein CD4 Market Size Forecast (2021-2026)
12.3.1 Europe: T Cell Surface Glycoprotein CD4 Sales Forecast (2021-2026)
12.3.2 Europe: T Cell Surface Glycoprotein CD4 Revenue Forecast (2021-2026)
12.3.3 Europe: T Cell Surface Glycoprotein CD4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific T Cell Surface Glycoprotein CD4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: T Cell Surface Glycoprotein CD4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: T Cell Surface Glycoprotein CD4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: T Cell Surface Glycoprotein CD4 Market Size Forecast by Region (2021-2026)
12.5 Latin America T Cell Surface Glycoprotein CD4 Market Size Forecast (2021-2026)
12.5.1 Latin America: T Cell Surface Glycoprotein CD4 Sales Forecast (2021-2026)
12.5.2 Latin America: T Cell Surface Glycoprotein CD4 Revenue Forecast (2021-2026)
12.5.3 Latin America: T Cell Surface Glycoprotein CD4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa T Cell Surface Glycoprotein CD4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: T Cell Surface Glycoprotein CD4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: T Cell Surface Glycoprotein CD4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: T Cell Surface Glycoprotein CD4 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key T Cell Surface Glycoprotein CD4 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T Cell Surface Glycoprotein CD4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. T Cell Surface Glycoprotein CD4 Market Segments
Table 2. Ranking of Global Top T Cell Surface Glycoprotein CD4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Forigerimod Acetate
Table 5. Major Manufacturers of HIV Vaccine 2
Table 6. Major Manufacturers of Ibalizumab
Table 7. Major Manufacturers of Others
Table 8. Global T Cell Surface Glycoprotein CD4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global T Cell Surface Glycoprotein CD4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global T Cell Surface Glycoprotein CD4 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Regions (2015-2020)
Table 12. Global T Cell Surface Glycoprotein CD4 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global T Cell Surface Glycoprotein CD4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global T Cell Surface Glycoprotein CD4 Sales Share by Manufacturers (2015-2020)
Table 15. Global T Cell Surface Glycoprotein CD4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global T Cell Surface Glycoprotein CD4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Surface Glycoprotein CD4 as of 2019)
Table 17. T Cell Surface Glycoprotein CD4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. T Cell Surface Glycoprotein CD4 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers T Cell Surface Glycoprotein CD4 Price (2015-2020) (USD/Pcs)
Table 20. T Cell Surface Glycoprotein CD4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers T Cell Surface Glycoprotein CD4 Product Type
Table 22. Date of International Manufacturers Enter into T Cell Surface Glycoprotein CD4 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global T Cell Surface Glycoprotein CD4 Sales by Type (2015-2020) (K Pcs)
Table 25. Global T Cell Surface Glycoprotein CD4 Sales Share by Type (2015-2020)
Table 26. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global T Cell Surface Glycoprotein CD4 Revenue Share by Type (2015-2020)
Table 28. T Cell Surface Glycoprotein CD4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global T Cell Surface Glycoprotein CD4 Sales by Application (2015-2020) (K Pcs)
Table 30. Global T Cell Surface Glycoprotein CD4 Sales Share by Application (2015-2020)
Table 31. North America T Cell Surface Glycoprotein CD4 Sales by Country (2015-2020) (K Pcs)
Table 32. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2015-2020)
Table 33. North America T Cell Surface Glycoprotein CD4 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2015-2020)
Table 35. North America T Cell Surface Glycoprotein CD4 Sales by Type (2015-2020) (K Pcs)
Table 36. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2015-2020)
Table 37. North America T Cell Surface Glycoprotein CD4 Sales by Application (2015-2020) (K Pcs)
Table 38. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2015-2020)
Table 39. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2015-2020)
Table 41. Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2015-2020)
Table 43. Europe T Cell Surface Glycoprotein CD4 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2015-2020)
Table 45. Europe T Cell Surface Glycoprotein CD4 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific T Cell Surface Glycoprotein CD4 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific T Cell Surface Glycoprotein CD4 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific T Cell Surface Glycoprotein CD4 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific T Cell Surface Glycoprotein CD4 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2015-2020)
Table 55. Latin America T Cell Surface Glycoprotein CD4 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa T Cell Surface Glycoprotein CD4 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2015-2020)
Table 59. Latin America T Cell Surface Glycoprotein CD4 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2015-2020)
Table 61. Latin America T Cell Surface Glycoprotein CD4 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2015-2020)
Table 71. Biotest AG Corporation Information
Table 72. Biotest AG Description and Major Businesses
Table 73. Biotest AG T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Biotest AG Product
Table 75. Biotest AG Recent Development
Table 76. Bristol-Myers Squibb Co Corporation Information
Table 77. Bristol-Myers Squibb Co Description and Major Businesses
Table 78. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Bristol-Myers Squibb Co Product
Table 80. Bristol-Myers Squibb Co Recent Development
Table 81. CEL-SCI Corp Corporation Information
Table 82. CEL-SCI Corp Description and Major Businesses
Table 83. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. CEL-SCI Corp Product
Table 85. CEL-SCI Corp Recent Development
Table 86. Fountain Biopharma Inc Corporation Information
Table 87. Fountain Biopharma Inc Description and Major Businesses
Table 88. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Fountain Biopharma Inc Product
Table 90. Fountain Biopharma Inc Recent Development
Table 91. Immupharma Plc Corporation Information
Table 92. Immupharma Plc Description and Major Businesses
Table 93. Immupharma Plc T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Immupharma Plc Product
Table 95. Immupharma Plc Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Major Businesses
Table 98. Sanofi T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. TaiMed Biologics Inc Corporation Information
Table 102. TaiMed Biologics Inc Description and Major Businesses
Table 103. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. TaiMed Biologics Inc Product
Table 105. TaiMed Biologics Inc Recent Development
Table 106. United Biomedical Inc Corporation Information
Table 107. United Biomedical Inc Description and Major Businesses
Table 108. United Biomedical Inc T Cell Surface Glycoprotein CD4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. United Biomedical Inc Product
Table 110. United Biomedical Inc Recent Development
Table 111. Global T Cell Surface Glycoprotein CD4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 112. Global T Cell Surface Glycoprotein CD4 Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global T Cell Surface Glycoprotein CD4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global T Cell Surface Glycoprotein CD4 Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 116. North America: T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Europe: T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: T Cell Surface Glycoprotein CD4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 120. Asia Pacific: T Cell Surface Glycoprotein CD4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. Latin America: T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: T Cell Surface Glycoprotein CD4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Middle East and Africa: T Cell Surface Glycoprotein CD4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key T Cell Surface Glycoprotein CD4 Players
Table 129. T Cell Surface Glycoprotein CD4 Customers List
Table 130. T Cell Surface Glycoprotein CD4 Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Surface Glycoprotein CD4 Product Picture
Figure 2. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type in 2020 & 2026
Figure 3. Forigerimod Acetate Product Picture
Figure 4. HIV Vaccine 2 Product Picture
Figure 5. Ibalizumab Product Picture
Figure 6. Others Product Picture
Figure 7. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application in 2020 & 2026
Figure 8. HIV
Figure 9. AIDS
Figure 10. GVHD
Figure 11. SARS
Figure 12. Others
Figure 13. T Cell Surface Glycoprotein CD4 Report Years Considered
Figure 14. Global T Cell Surface Glycoprotein CD4 Market Size 2015-2026 (US$ Million)
Figure 15. Global T Cell Surface Glycoprotein CD4 Sales 2015-2026 (K Pcs)
Figure 16. Global T Cell Surface Glycoprotein CD4 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2015-2020)
Figure 18. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Region in 2019
Figure 19. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2015-2020)
Figure 20. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region in 2019
Figure 21. Global T Cell Surface Glycoprotein CD4 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by T Cell Surface Glycoprotein CD4 Revenue in 2019
Figure 23. T Cell Surface Glycoprotein CD4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2015-2020)
Figure 25. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type in 2019
Figure 26. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2015-2020)
Figure 27. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type in 2019
Figure 28. Global T Cell Surface Glycoprotein CD4 Market Share by Price Range (2015-2020)
Figure 29. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2015-2020)
Figure 30. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application in 2019
Figure 31. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2015-2020)
Figure 32. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application in 2019
Figure 33. North America T Cell Surface Glycoprotein CD4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America T Cell Surface Glycoprotein CD4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2019
Figure 36. North America T Cell Surface Glycoprotein CD4 Revenue Market Share by Country in 2019
Figure 37. U.S. T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America T Cell Surface Glycoprotein CD4 Market Share by Type in 2019
Figure 42. North America T Cell Surface Glycoprotein CD4 Market Share by Application in 2019
Figure 43. Europe T Cell Surface Glycoprotein CD4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe T Cell Surface Glycoprotein CD4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2019
Figure 46. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Country in 2019
Figure 47. Germany T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe T Cell Surface Glycoprotein CD4 Market Share by Type in 2019
Figure 58. Europe T Cell Surface Glycoprotein CD4 Market Share by Application in 2019
Figure 59. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific T Cell Surface Glycoprotein CD4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Region in 2019
Figure 62. Asia Pacific T Cell Surface Glycoprotein CD4 Revenue Market Share by Region in 2019
Figure 63. China T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific T Cell Surface Glycoprotein CD4 Market Share by Type in 2019
Figure 86. Asia Pacific T Cell Surface Glycoprotein CD4 Market Share by Application in 2019
Figure 87. Latin America T Cell Surface Glycoprotein CD4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America T Cell Surface Glycoprotein CD4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2019
Figure 90. Latin America T Cell Surface Glycoprotein CD4 Revenue Market Share by Country in 2019
Figure 91. Mexico T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America T Cell Surface Glycoprotein CD4 Market Share by Type in 2019
Figure 98. Latin America T Cell Surface Glycoprotein CD4 Market Share by Application in 2019
Figure 99. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue Market Share by Country in 2019
Figure 103. Turkey T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E T Cell Surface Glycoprotein CD4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E T Cell Surface Glycoprotein CD4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa T Cell Surface Glycoprotein CD4 Market Share by Type in 2019
Figure 110. Middle East and Africa T Cell Surface Glycoprotein CD4 Market Share by Application in 2019
Figure 111. North America T Cell Surface Glycoprotein CD4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America T Cell Surface Glycoprotein CD4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe T Cell Surface Glycoprotein CD4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe T Cell Surface Glycoprotein CD4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific T Cell Surface Glycoprotein CD4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific T Cell Surface Glycoprotein CD4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America T Cell Surface Glycoprotein CD4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America T Cell Surface Glycoprotein CD4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa T Cell Surface Glycoprotein CD4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
T細胞特異的表面糖タンパク質CD28の世界市場（～2026年） Market Analysis and Insights: Global T Cell Specific Surface Glycoprotein CD28 Market The global T Cell Specific Surface Glycoprotein CD28 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Specific Surface Glycopr…- T細胞表面糖タンパク質CD3イプシロン鎖の世界市場（～2026年） Market Analysis and Insights: Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market The global T Cell Surface Glycoprotein CD3 Epsilon Chain market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Surface Glycopro…
- 細胞表面マーカー検出の世界市場（～2026年） Cell surface markers are also known as cell surface antigen serves as monograms to help identify and classify cells. There is an increase in demand for the cell surface marker detection market owing to the advancements in high-throughput tools and techniques used for cytological analysis. Market Ana…
- 細胞培養タンパク質表面コーティングの世界市場（～2026年） Cell culture is a complex procedure in which cells are grown under controlled physical conditions outside the natural environment. These cells are used to develop model systems for research, study of cellular structure and functions, stem cell research, drug discovery and genetic engineering. Growin…
- 呼吸器合胞体ウイルス付着糖タンパク質の世界市場（～2026年） Market Analysis and Insights: Global Respiratory Syncytial Virus Attachment Glycoprotein Market The global Respiratory Syncytial Virus Attachment Glycoprotein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Respiratory…